Investors snack before $25bn Abbvie
High grade dollar bond investors are braced for the biggest deal of the year after AbbVie, the pharmaceutical company, appointed a trio of banks to lead a possible $25bn issue that could come as soon as Monday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: